Skip to main content

Table 1 Positivity of biological markers of congenital toxoplasmosis in infected newborns from mothers treated with spiramycin (Group 1) and from untreated mothers (Group 2)

From: Assessment of laboratory methods used in the diagnosis of congenital toxoplasmosis after maternal treatment with spiramycin in pregnancy

  Group 1 Group 2 pa
Infected (N = 27) Infected (N = 19)
  n% Sensibility (%) n% Sensibility (%)  
PCR 1 (3,70) 3,7 6 (31,58) 31,58 0,053
Positive
Negative 26 (96,30)   13 (68,42)   
IgM 7 (25,93) 25,93 13 (68,42) 68,42 0,0662
Positive
Negative 20 (74,07)   6 (31,58)   
IgA 3 (11,11) 11,11 7 (36,84) 36,84 0,0969
Positive
Negative 24 (88,89)   12 (63,16)   
  1. aFisher’s Exact Test.
  2. (Goiânia-GO, Brazil, 2012).